Problems with using exhaled nitric oxide to guide asthma treatment - 20/08/11
F. E. Hargreave is supported by the Father Sean O’Sullivan Research Centre. K. Parameswaran is supported by a Canada Research Chair in Airway Diseases. Disclosure of potential conflict of interest: F. E. Hargreave has received grant support from GlaxoSmithKline and has patent licensing arrangements on a device to process sputum that is not taken up by industry. K. Parameswaran has received grant support from AstraZeneca, GlaxoSmithKline, and Sepracor. |
Vol 117 - N° 6
P. 1511 - juin 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?